These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8290340)

  • 21. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
    Cohen DR; Curran T
    Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity.
    Xanthoudakis S; Curran T
    EMBO J; 1992 Feb; 11(2):653-65. PubMed ID: 1537340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Redox regulation of DNA-binding activity of fos and jun oncogene proteins in vitro].
    Medzhitov RM
    Biokhimiia; 1991 Dec; 56(12):2297-8. PubMed ID: 1807408
    [No Abstract]   [Full Text] [Related]  

  • 24. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
    Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding.
    Walker LJ; Robson CN; Black E; Gillespie D; Hickson ID
    Mol Cell Biol; 1993 Sep; 13(9):5370-6. PubMed ID: 8355688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A conserved region adjacent to the basic domain is required for recognition of an extended DNA binding site by Maf/Nrl family proteins.
    Kerppola TK; Curran T
    Oncogene; 1994 Nov; 9(11):3149-58. PubMed ID: 7936637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of c-Fos and c-Jun redox-dependent DNA binding activity.
    Xanthoudakis S; Curran T
    Methods Enzymol; 1994; 234():163-74. PubMed ID: 7808290
    [No Abstract]   [Full Text] [Related]  

  • 28. Amino acid residues required for physical and cooperative transcriptional interaction of STAT3 and AP-1 proteins c-Jun and c-Fos.
    Ginsberg M; Czeko E; Müller P; Ren Z; Chen X; Darnell JE
    Mol Cell Biol; 2007 Sep; 27(18):6300-8. PubMed ID: 17636030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Energy transfer analysis of Fos-Jun dimerization and DNA binding.
    Patel LR; Curran T; Kerppola TK
    Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7360-4. PubMed ID: 8041795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changing fos oncoprotein to a jun-independent DNA binding protein with GCN4 dimerization specificity by swapping "leucine zippers".
    Sellers JW; Struhl K
    Nature; 1989 Sep; 341(6237):74-6. PubMed ID: 2505087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Redox regulation of c-Jun DNA binding by reversible S-glutathiolation.
    Klatt P; Molina EP; De Lacoba MG; Padilla CA; Martinez-Galesteo E; Barcena JA; Lamas S
    FASEB J; 1999 Sep; 13(12):1481-90. PubMed ID: 10463938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear translocation of Fos is stimulated by interaction with Jun through the leucine zipper.
    Chida K; Nagamori S; Kuroki T
    Cell Mol Life Sci; 1999 Feb; 55(2):297-302. PubMed ID: 10188588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The binding of a Fos/Jun heterodimer can completely disrupt the structure of a nucleosome.
    Ng KW; Ridgway P; Cohen DR; Tremethick DJ
    EMBO J; 1997 Apr; 16(8):2072-85. PubMed ID: 9155033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.
    Petz LN; Ziegler YS; Schultz JR; Nardulli AM
    Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why the c-Fos/c-Jun complex is extremely conserved: An in vitro evolution exploration by combining cDNA display and proximity ligation.
    Kang SK; Chu XY; Tian T; Dong PF; Chen BX; Zhang HY
    FEBS Lett; 2019 May; 593(10):1040-1049. PubMed ID: 31002393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
    Manna PR; Eubank DW; Stocco DM
    Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The designed protein M(II)-Gly-Lys-His-Fos(138-211) specifically cleaves the AP-1 binding site containing DNA.
    Harford C; Narindrasorasak S; Sarkar B
    Biochemistry; 1996 Apr; 35(14):4271-8. PubMed ID: 8605175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of c-Jun concentration in neuronal cell death.
    Rössler OG; Steinmüller L; Giehl KM; Thiel G
    J Neurosci Res; 2002 Dec; 70(5):655-64. PubMed ID: 12424733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.